Australian semiconductor company Archer Materials (ASX: AXE) is one step closer to the commercialisation of their graphene-based Biochip, a recent design of which has been successfully manufactured by foundry partner Graphenea in Spain, carving a pathway towards its future production. The milestone advances Archer’s Biochip capabilities in access to commercial semiconductor production facilities for technologies
Read More
According to UBS, 3.16 billion people cannot reach a healthcare facility by foot within an hour, with many battling with poverty and inaccessibility to resources. But what if people didn’t have to delay? What if they could use a microchip to diagnose, monitor and upload their data, which a doctor could digitally survey? That’s the
Read More
Australian semiconductor company Archer Materials (ASX: AXE) is one step closer to the next generation of medical diagnostics through the successful manufacture of its graphene ‘lab-on-a-chip’ biochip in a commercial semiconductor foundry. Scaling the design and production of graphene chips to be used as biological sensors is a significant challenge to commercialising what could potentially
Read More
Australian semiconductor company Archer Materials (ASX: AXE) has taken a major step forward towards the commercialisation of its biosensing graphene transistor technology with the transfer of its chip designs to a commercial foundry to initiate a production run. The company’s partnerships with international semiconductor fabs have advanced this year, with Archer having completed its optical
Read More
*Owners of this website are shareholders in a company mentioned in this article and have been engaged by them to assist in investor communications
Read More
